EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Chlorhexidine gluconate for antisepsis in preterm neonates: A review of safety and efficacy

Jamie B Harris iD, Reesa L Monir, Jennifer J Schoch iD

Pediatric Dermatology · 2024-09 · 41 (5) · 786-792

DOI: 10.1111/pde.15709 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Dermatology, online erschienen am 25.07.2024. Verfasst von Jamie B Harris und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida College of Medicine, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Chlorhexidine, Infant, Premature, Anti-Infective Agents, Local, Antisepsis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a leading cause of death in preterm neonates. The increased susceptibility to sepsis is due to prolonged hospitalization, the need for invasive procedures, and immaturity of innate and adaptive immunity. Chlorhexidine gluconate is a popular topical disinfectant that was not recommended for use in preterm neonates until 2012. Thus, there are few studies assessing the role of chlorhexidine gluconate in antisepsis for preterm neonates. A better understanding of the safety and efficacy of chlorhexidine gluconate as an antiseptic agent for preterm neonates is the first step in establishing best practice guidelines for this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChlorhexidineInfant, PrematureAnti-Infective Agents, LocalAntisepsisHumansInfant, NewbornSepsis

Stichwörter der Autor:innen

antisepticchlorhexidinechlorhexidine gluconatepretermsepsis

Substanzen

Chlorhexidinechlorhexidine gluconateAnti-Infective Agents, Local

Autor:innen und Institutionen

  • University of Florida College of Medicine, Gainesville, Florida, USA.
  • Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Dermatology, University of Florida College of Medicine, Gainesville, Florida, USA.

ORCID-Profile: Jamie B Harris, Jennifer J Schoch

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Harris, J. B., Monir, R. L., & Schoch, J. J. (2024). Chlorhexidine gluconate for antisepsis in preterm neonates: A review of safety and efficacy. Pediatric Dermatology, 41(5), 786-792. https://doi.org/10.1111/pde.15709

Vancouver

Harris JB, Monir RL, Schoch JJ. Chlorhexidine gluconate for antisepsis in preterm neonates: A review of safety and efficacy. Pediatric Dermatology. 2024;41(5):786-792. doi:10.1111/pde.15709

BibTeX
@article{Harris2024,
  author = {Harris, Jamie B and Monir, Reesa L and Schoch, Jennifer J},
  title = {Chlorhexidine gluconate for antisepsis in preterm neonates: A review of safety and efficacy},
  journal = {Pediatric Dermatology},
  year = {2024},
  volume = {41},
  number = {5},
  pages = {786--792},
  doi = {10.1111/pde.15709}
}
Kostenlos starten →